Traws Pharma, Inc. (TRAW) — Revenue

Annual figures by fiscal year, from SEC filings.

2011: $1.49M2012: $46.19M2013: $4.75M2014: $800.0K2015: $11.46M2016: $5.55M2017: $787.0K2018: $1.23M2019: $2.18M2020: $231.0K2021: $226.0K2022: $226.0K2023: $226.0K2024: $226.0K2025: $2.79M$2.79M
2011Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$2.79M+1134.5%
2024$226.0K+0.0%
2023$226.0K+0.0%
2022$226.0K+0.0%
2021$226.0K-2.2%
2020$231.0K-89.4%
2019$2.18M+77.8%
2018$1.23M+56.0%
2017$787.0K-85.8%
2016$5.55M-51.6%
2015$11.46M+1332.0%
2014$800.0K-83.2%
2013$4.75M-89.7%
2012$46.19M+3006.3%
2011$1.49M